Sebia

📍 Lisses, France🗓 Founded 1967👥 429 employees💰 Last funded Dec 2023
Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions. Sebia is a Global specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy and other rare pathologies. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1967
Founded
Investor geography2 countries
United Kingdom
1
France
1
Frequently asked questions
Who invested in Sebia?
Sebia has 2 investors on record on gritt.io.
When did Sebia last raise funding?
The most recent investment in Sebia recorded on gritt.io was in December 2023.
When was Sebia founded?
Sebia was founded in 1967.
What industry is Sebia in?
Sebia operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sebia based?
Sebia is headquartered in Lisses, France.